Product | 11.02.2022
Huvepharma Receives FDA Approval for Tilmovet® AC (Tilmicosin Phosphate)
Huvepharma announces FDA approval for Tilmovet® AC (tilmicosin phosphate), an aqueous concentrate for the control of swine respiratory disease associated with Pasturella multocida and Haemophilus parasuis in groups of swine in buildings where a respiratory disease outbreak is diagnosed.
